269 |
Surrogate Markers of CHD & Statins |
Wolfgang Koenig |
Nov. 24. 06 |
268 |
The Cholesterol Balance: The Advanced Approach to Dyslipidemia Management |
Peter Jan Lansberg |
Nov. 24. 06 |
267 |
Application of 'Bone Marrow Mononuclear Cells' for Pts with MI; Lessons from BOOST Program |
Kai C. Wollert |
Nov. 24. 06 |
266 |
Medical Treatment for Patients with Post-Myocardial Infarction - Importance of Angiotensin Receptor Blockers |
Yuji Ikari |
Nov. 10. 06 |
265 |
Lipid Treatment in Post PCI Patients |
Donghoon Choi |
Nov. 10. 06 |
264 |
Optimising Antiplatelet Therapy in Patients with STEMI: Main Findings of CLARITY and COMMIT |
Zhengming Chen |
Nov. 10. 06 |
263 |
Insights into STEMI |
Seong-Wook Park |
Nov. 10. 06 |
262 |
Medical Environment Post-PCI |
Jean Fajadet |
Oct. 27. 06 |
261 |
Consensus and Questions to Be Resolved in Bifurcation Lesions |
Thierry Lefevre |
Oct. 27. 06 |
260 |
Percutaneous PCI in Diabetic Patients |
Angela Hoye |
Oct. 27. 06 |